NEW YORK, Jan. 13, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is reminding investors that class action lawsuits can be filed on behalf of Twist Bioscience Corp. shareholders TWSTSunlight Financial Holdings, Inc. SUNLGaia, Inc. GAIAand Tattooed Chef, Inc. TTCF. Shareholders have until the deadlines below to petition the court to appear as lead plaintiffs. For more information on each case, see the link provided.

Twist Bioscience Corp TWST

Class period: December 13, 2019 – November 14, 2022

Lead Plaintiff Deadline: February 10, 2023

Twist, a Delaware company headquartered in South San Francisco, California, is a biotechnology company that produces synthetic DNA and DNA products. Synthetic DNA products allow users to design and modify DNA for purposes such as academic research, improving the production of specialty chemicals, and developing healthcare treatments, among other uses. Twist’s common stock is traded in the United States on the Nasdaq Global Select Market (“NASDAQ”) under the ticker symbol “TWST.”

During the class period, the defendants repeatedly assured investors that the company had innovative proprietary technology related to its synthetic DNA products that positioned Twist for significant future growth. In fact, the defendants alleged that the Company had already achieved significant growth during the class period, growing from a customer base of approximately 1,300 diagnostics companies, hospitals, research institutions and others at the end of fiscal 2019 to approximately 2,900 customers at the end of fiscal 2021.

Similarly, the defendants reported skyrocketing gross margins, allegedly rising from 12.8% in fiscal 2019 to 39.1% in fiscal 2021, with fiscal 2022 margins expected to hit 40%.

During the Class Period, the Defendants also announced plans to build a “Factory of the Future” in Wilsonville, Oregon (the “Oregon…